emphysema as an inclusion criterion in lung can cer screening (along with age and tobacco con sumption). They used data from the Pilot Silesian study for Early Lung Cancer Detection using low dose computed tomography and included 601 as ymptomatic volunteers with a smoking history. This study revealed an association between em physema and those SPN characteristics which previous evidence had shown to be related with SPN malignancy in a high risk population. 3 Em physema was closely correlated with risk factors for lung cancer, such as qualitative and quanti tative SPN characteristics related to malignancy (morphology, size, and localization) and patient characteristics such as age and heavy smoking.
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However, Wachuła et al 3 did not evaluate an as sociation between emphysema and SPN malignan cy as this was not their aim. In addition, the small size of the study group and limitations to the radi ologists' interpretation would have made this dif ficult. Nonetheless, the authors did establish a re lationship between SPNs and emphysema, which highlights the relevance of including the pres ence of emphysema as a new inclusion criteri on for screening. In addition, these results ques tion the inclusion of only current age and tobac co exposure as screening criteria. In fact, 80% of screened patients with lung cancer had previous ly suffered from chronic obstructive pulmonary disease, emphysema, or both. 10 Experts have called for the modification of in clusion criteria in lung cancer screening stud ies to include all highrisk individuals, particu larly because of the increasing incidence of lung cancer in nonsmokers. This particularly bene fits women, given the high incidence of lung can cer in neversmoking women, 11,12 and those pop ulations who have been exposed to lung carcin ogens such as asbestos or air pollution (223 000 lung cancer deaths annually could be attributed to particulate matter less than 2.5 μm in aerody namic diameter). 13 However, further prospective studies are needed to clarify the utility of includ ing emphysema as a new criterion in a lung can cer screening program.
Lung cancer is the leading cause of cancer related mortality worldwide. 1,2 In Poland, where Wachuła et al 3 conducted their study, lung cancer is re sponsible for over 31% and 16% of cancer deaths in men and women, respectively, 4 and a program for the detection of early lung cancer will short ly be introduced. 5 The U.S. Preventive Services Task Force recom mends (grade B) annual screening in adults aged 55 to 80 years who have a smoking history of 30 pack years and are current smokers or have giv en up smoking within the past 15 years. However, concerns have been raised about limiting screen ing selection criteria to age and smoking habit, because lung cancer could be missed in individu als who are younger, are lighter smokers, or both (particularly women). 6 A previous study showed that factors associated with solitary pulmonary nodule (SPN) malignancy and 5 year lung cancer mortality were different for men and women, es pecially smoking history, where a relatively high rate of lung cancer diagnosis was found in wom en classified as nonsmokers. 7
The National Lung Screening Trial revealed that the presence of emphysema was clearly associated with an increased risk of death from lung cancer (hazard ratio, 1.56; 95% CI, 1.20-2.04). The Brock model, developed from the data set of the Pan Canadian Early Detection of Lung Cancer Study (PanCan) conducted by the British Columbia Can cer Agency (1871 persons with 7008 SPNs) and val idated in a clinical population, 8 includes emphyse ma in its management algorithms for suspicious SPN, along with older age, female sex, family histo ry of lung cancer, and nodule characteristics (larg er nodule size, location of the nodule in the upper lobe, part solid nodule type, lower number of nod ules, and spiculated borders). This model is recom mended by the British Thoracic Society. 9
It is likely, therefore, that the use of emphyse ma as a screening criterion would provide an ad ditional means of identifying at risk individuals who might benefit from screening. Wachuła et al 3 analyzed the relationship between emphyse ma and SPN characteristics in order to consider EDITORIAL Emphysema and lung cancer screening Elisa Chilet Rosell 1,2 , Blanca Lumbreras 1,2 1 Public Health, History of Science and Gynaecology Department, Miguel Hernández University, Alicante, Spain 2 CIBER in Epidemiology and Public Health, Madrid, Spain
